For Boehringer Ingelheim, this includes Stiolto Respimat. The price for inhalers like Stiolto Respimat was capped at $35. Learn more about Stiolto Respimat. Each Part D plan has a monthly premium ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback